Altogether, mTOR and Src stand as the two major intrinsic targets downstream of receptor tyrosine kinases, and are found to be dually activated in almost half of the HER2+ BC cases exhibiting the highest rate of co-activation (Yori et al., 2014). Here, SRC is linked to breast cancer.